Top 3

Viking’s Stock Craters After Mid-Stage Obesity Trial Data With Oral Drug VK7235

Tern Makes Shift In Pipeline To Cancer Asset TERN-701 As Obesity Space Gets Crowded

AstraZeneca’s Late-Stage Study Win In Treatment Resistant-Hypertension Bolsters Baxdrostat’s Advancement

iTeos Doubles Down On Strategic Alternatives After TIGIT Failures

Rallybio Scraps Maternal Disorder Candidate RLYB212 Shifting Focus To C5 Inhibitor

Scroll to Top